PV pharm branch, vendor, cage 0U9U0
Ended Awarded Last action
- Contract number
- SPE2D826F05J3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $83,010
Award facts
- Contract value 100% obligated
- $83,009.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $83,009.90 to AmerisourceBergen Drug Corp on December 8, 2025, with a completion date of December 9, 2025. This competitively awarded, non-set-aside contract reflects a firm fixed price delivery order for pharmaceutical products and medical supplies to support federal medical procurement needs. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical prime vendor for the Defense Logistics Agency's comprehensive pharmaceutical support vehicle, enabling the delivery of a broad range of medical commodities including brand-name and generic medications, vaccines, and specialized healthcare products across multiple therapeutic domains to support military healthcare programs globally.
This delivery order represents typical transactional activity under AmerisourceBergen's prime indefinite delivery contract with DLA. The company's federal contract portfolio demonstrates extensive capability in fulfilling competitive pharmaceutical procurement requirements for Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The DLA's Pharmaceutical Prime Vendor Global Program Generation V initiative, under which this contract operates, is structured to enable multiple awards across separate regions, positioning AmerisourceBergen as a key strategic vendor for federal medical supply distribution within the defense healthcare ecosystem.
Quick answers
Who was awarded contract SPE2D826F05J3?
SPE2D826F05J3 was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on December 8, 2025.
How much is contract SPE2D826F05J3 worth?
The government has obligated $83,010 on SPE2D826F05J3.
Is contract SPE2D826F05J3 an order under another contract?
Yes. SPE2D826F05J3 is a delivery order under SPE2DX22D0069, an indefinite delivery contract.
Was contract SPE2D826F05J3 competed?
The extent of competition for SPE2D826F05J3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award